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Several studies have examined the significance of prolonged QRS duration, in the absence of 
bundle branch block (BBB), for predicting mortality in patients post ST elevation myocardial 
infarction (STEMI).1, 2 Few have studied this relationship in the non ST elevation myocardial 
infarction (NSTEMI) population, especially in the post thrombolytic era. The primary endpoints 
of this study were to determine whether prolonged admission QRS in the absence of BBB 
predicts 30 day and one year mortality in NSTEMI patients. A secondary endpoint was to 
determine the relationship between prolonged QRS and occurrence of in-patient ventricular 
tachyarrhythmias after NSTEMI. 
One thousand nine hundred and sixty patients admitted to Einstein Medical Center, Philadelphia 
from August 1, 2006 to August 31, 2011 with a diagnosis of NSTEMI were screened.  The study 
protocol was approved by the Einstein Institutional Review Board. The author(s) of this 
manuscript have certified that they comply with the principles of ethical publishing in the 
International Journal of Cardiology3. 
NSTEMI was diagnosed on the basis of cardiac symptoms and electrocardiographic changes 
consisting of ST depression in two contiguous leads and positive troponins in accordance with 
existing guidelines4. Patients with known prior QRS >110ms, BBB, paced rhythm or incomplete 
data sets were excluded. Admission EKGs, as well as telemetry data, were reviewed to determine 
QRS duration and development of inpatient ventricular arrhythmias (ventricular tachycardia 
(VT) and ventricular fibrillation (VF)) during the index hospital stay.  QRS durations from fifty 
random EKGs were measured by both manual and electronic means and then compared to 
ascertain accuracy and reliability of the electronic method of collection which was eventually 
used for EKG measurements (R2=0.96, P<0.0001). Data on patient demographics, clinical 
characteristics, baseline hemodynamic parameters, ejection fraction (obtained from transthoracic 
echocardiogram reports) and type of intervention performed (percutaneous coronary intervention 
(PCI) or coronary artery bypass graft (CABG)) were collected. Mortality at 30 days and one year 
were determined from hospital records and the publicly accessed social security death index 
website. 
Baseline characteristics of patients with a prolonged QRS >110 ms versus those with a QRS 
<100 ms were compared using independent-sample t tests for continuous variables and chi-
square for discrete variables. Multivariate Cox proportional hazards regression models were used 
to evaluate independent predictors of mortality. Kaplan-Meier method was used for generating 
survival curves and compared using the log-rank test. Effect of each variable was expressed as an 
odds ratio (OR) and confidence interval (CI). A p value <0.05 was considered statistically 
significant. Statistical analyses were performed using SPSS, version 22. 
The final cohort consisted of 1539 patients with mean age of 66+14year, 51% were female and 
the average QRS for the entire cohort was 90.5+13.5ms. Demographics, clinical and 
hemodynamic characteristics are listed in Table 1. A cut off of QRS >110ms was used as it 
yielded the best specificity, negative predictive value and accuracy for predicting mortality 
(91%, 91% and 84%, respectively). On multivariate analysis, patients with QRS >110ms had 
increased 30-day mortality (HR=1.9, 95%CI 1.10-3.23; p=0.02) (Table 1) and one-year mortality 
(HR=1.44, 95%CI 1.002-2.059; p=0.05) (Table 1), even after adjusting for known coronary 
artery disease risk factor variables, chronic kidney disease and revascularization. Chronic kidney 
disease was predictive of one year mortality, but not for 30 day mortality (Table 1). Kaplan-
Meier curves stratified by QRS >110ms versus QRS <110ms showed an increase in both 30 day 
and one-year mortality in patients with prolonged QRS (Figure 1).  
During hospitalization of NSTEMI patients with QRS >110ms, 21.8% experienced VT and 3.2% 
had VF compared to 10.3% and 0.9% of patients with QRS <110ms. The odds of having in-
patient ventricular tachycardia and ventricular fibrillation was 2.4 (OR=2.4, 95%CI 1.5-3.8) and 
3.6(OR=3.6, 95%CI 1.2-11.2) times higher in patients with QRS >110ms compared to patients 
with QRS <110ms.  
Studies have shown that prolonged QRS duration due to the presence of bundle branch block 
increased short term mortality in patients presenting with ST elevation myocardial infarction 
(STEMI)5, 6. Even in the absence of bundle branch block, prolonged QRS has been shown to 
predict increased mortality in STEMI patients2, 7. Several hypotheses have been put forward to 
explain this finding. Some postulated that QRS prolongation might be due to scar tissue 
formation affecting the conduction system, which could predispose to reentry and ultimately 
ventricular arrhythmias8, 9. Others hypothesized that QRS prolongation post STEMI may be due 
to late potentials which are large enough to affect the surface EKG and they point to extensive 
infarcts and involvement of the interventricular system and hence, increased mortality7. Few 
studies have examined this relationship in NSTEMI patients. 
Our study demonstrates that a QRS >110ms in patients presenting with NSTEMI is associated 
with increased short and long term mortality in the absence of bundle branch block. We believe 
that the initial QRS duration measured upon presentation with NSTEMI can help with 
stratification of this patient population as we demonstrated that patients with NSTEMI and 
QRS>110ms have a 90% increased risk of dying within 30 days. Given that only 14 patients 
need to be aggressively treated to save one life at 30 days post NSTEMI, it is not unreasonable to 
use the QRS duration as a tool to stratify at risk patients into a group that might benefit from 
more aggressive care. For example these patients could be discharged with a wearable 
cardioverter defibrillator to help terminate ventricular arrhythmias and therefore prevent sudden 
cardiac death versus having them routinely followed up10.  
Study limitations included knowing the specificcause of death after patients left the hospital, 
such that 30 day mortality was all cause mortality, which is less reliable in demonstrating a direct 
cause and effect relationship. Finally, our subject population was predominantly black which 
might limit generalizing our results to other populations. 
In conclusion, QRS duration >110ms, in the absence of a BBB, is an independent predictor of 
30-day and one-year mortality after NSTEMI. A QRS duration >110ms after NSTEMI is also 
associated with increased occurrence of in-patient ventricular arrhythmias. 
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Table Legends 
Table 1: Multivariate Analysis for QRS >110ms and:  
(a) 30 day all-cause mortality 
(b) One year all-cause mortality 
 
Figure Legends 
Figure 1: Kaplan-Meier Survival Estimates (30 Day Mortality and One Year Mortality) 
 
 
 
Table 1 
Multivariate predictors for QRS >110ms and 30 day or 1 year all-cause mortality 
30 DAY MORTALITY HR (95% CI) P value 
QRS duration on admission 1.88 (1.10-3.23) 0.02 
Age 1.04 (1.02-1.06) 0.01 
Revascularization 0.24 (0.13-0.45) 0.00 
Ejection Fraction 0.27 (0.76-0.95) 0.04 
1 YEAR MORTALITY HR (95% CI) P value 
QRS on admission 1.44 (1.002-2.059) 0.05 
Age 1.05 (1.04-1.06) 0.00 
Chronic Kidney Disease 1.60 (1.25-2.06) 0.00 
Ejection Fraction 0.30 (0.14-0.63) 0.00 
Revascularization 0.38 (0.28-0.51) 0.00 
 
 
 
 
 
 
 
 
 
 
Figure 1 
Kaplan-Meier Survival Estimates (30 Day Mortality and One Year Mortality) 
 
